Hany Massarany

Hany Massarany, listed as board member, has filed trades across 3 companies (mainly through SEC (Form 4)), most often in Accelerate Diagnostics, Inc, Biodesix Inc and GenMark Diagnostics, Inc. Over a trading history stretching from 21 January 2016 to 1 July 2025, the count stands at 14 filings.

On the open market, the record shows 5 purchases worth €278k and 2 sales. The totals do not cover 3 filings with an undisclosed amount. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. The rest of the record consists of 1 share grant and 6 option exercises.

The median purchase comes to €52k. Of 5 purchases, 4 formed part of a group of insiders buying within 30 days of each other. A cluster is several different insiders buying the same stock within a short window, a pattern studied more closely than a single purchase.

The newest entry dates from 2 July 2025: an option exercise, in Biodesix Inc. The clock since the last published purchase (6 November 2024) now reads 711 days. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. For comparison, the SEC allows two business days to file a Form 4. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.